Advances in immunology - Autoimmune diseases

[31] Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (09) : 1339 - 1351

[32] Immunologic determinants of susceptibility to experimental glomerulonephritis: Role of cellular immunity [J]. KIDNEY INTERNATIONAL, 1997, 51 (03) : 646 - 652

[33] Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis:: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation [J]. JOURNAL OF NEUROLOGY, 2000, 247 (05) : 376 - 382

[34] Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) : 1573 - 1584

[35] Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection [J]. IMMUNITY, 1998, 8 (04) : 497 - 508

[36] The aetiology of type 1 diabetes: an epidemiological perspective [J]. ACTA PAEDIATRICA, 1998, 87 : 5 - 10

[37] Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 2913 - 2916

[38] DANG H, 1995, J IMMUNOL, V155, P3205

[39] Denham W, 1997, AM SURGEON, V63, P1045

[40] Impaired Fas response and autoimmunity in Pten+/- mice [J]. SCIENCE, 1999, 285 (5436) : 2122 - 2125

[31] Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (09) : 1339 - 1351

[32] Immunologic determinants of susceptibility to experimental glomerulonephritis: Role of cellular immunity [J]. KIDNEY INTERNATIONAL, 1997, 51 (03) : 646 - 652

[33] Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis:: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation [J]. JOURNAL OF NEUROLOGY, 2000, 247 (05) : 376 - 382

[34] Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) : 1573 - 1584

[35] Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection [J]. IMMUNITY, 1998, 8 (04) : 497 - 508

[36] The aetiology of type 1 diabetes: an epidemiological perspective [J]. ACTA PAEDIATRICA, 1998, 87 : 5 - 10

[37] Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 2913 - 2916

[38] DANG H, 1995, J IMMUNOL, V155, P3205

[39] Denham W, 1997, AM SURGEON, V63, P1045

[40] Impaired Fas response and autoimmunity in Pten+/- mice [J]. SCIENCE, 1999, 285 (5436) : 2122 - 2125